ROOT Stock Recent News

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for PBGENE-HBV. PBGENE-HBV is Precision's lead wholly owned in vivo gene editing program designed to cure chronic hepatitis B by eliminating c.

Russian President Vladimir Putin thanked U.S. President Donald Trump for giving "so much attention" to the prospect of a Russia-Ukraine deal.

Despite broad market volatility, momentum remains a powerful indicator of future price trends. Over the past month, a few standout stocks have climbed at least 20%, catching the attention of investors looking for sustained upside.

Since the start of 2024, Root's (ROOT 7.86%) stock has surged 1,262% higher. The surge reflects the disruptive insurance company's solid progress in several key areas.

Canadian charity Jack.org, the International Association for Youth Mental Health, and partners will lead Vancouver conference on March 18th-21st to develop a blueprint for global action on youth mental health Canadian charity Jack.org, the International Association for Youth Mental Health, and partners will lead Vancouver conference on March 18th-21st to develop a blueprint for global action on youth mental health

Root (ROOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Root Insurance's profitability and growth have led to a re-rating from Buy to Hold due to increased share price and tariff uncertainties. Q4 showed revenue growth and an improved balance sheet, but increased expenses led to a slight EPS decline. Debt refinancing reduced interest expenses, enhancing future earnings potential, while tangible book value per share increased.

Root, Inc. (NASDAQ:ROOT ) Q4 2024 Results Conference Call February 26, 2025 5:00 PM ET Company Participants Matt LaMalva - Head, Investor Relations Alex Timm - Co-Founder & Chief Executive Officer Megan Binkley - Chief Financial Officer Conference Call Participants Tommy McJoynt - KBW Elyse Greenspan - Wells Fargo Operator Greetings and welcome to Root Inc. Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Insurance company Root Inc ROOT reported fourth-quarter financial results after market close Wednesday.

COLUMBUS, Ohio, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced financial results for the fourth quarter and full year ended December 31, 2024. The company's latest financial results, along with management commentary, is detailed in the shareholder letter available on Root's investor relations website. An updated investor presentation is also accessible. Both can be found at ir.joinroot.com .